Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $285K | +8.33K | +9.72% | $34.20 | 94K | Nov 17, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$1.09M | -8.33K | -8.86% | $131.05 | 85.7K | Nov 17, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.33K | -100% | $0.00* | 0 | Nov 17, 2022 | Common Stock | 8.33K | $34.20 | Direct | F3 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | Reflects sales of common stock executed in multiple transactions at prices ranging from $130.931 to $131.540. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F3 | Options vested at a rate of 25% on each anniversary of the vesting commencement date of March 20, 2018 until all options were fully vested four years from the vesting commencement date. |